On May 21, Baoji Pharma-B fell 5.02% in regular trading, trading at 25.5 HKD/share, with trading volume of 35.57 million HKD.
Within the Biotechnology sector where Baoji Pharma-B belongs, the overall sector performed strongly. Among individual stocks, AKESO up 6.09%, REMEGEN up 4.31%, INNOVENT BIO up 2.83%, BEIGENE up 1.93%, 3SBIO up 0.52%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments